HRAS and papilloma: Only the oncogenic hotspot mutations in HRAS (83%) were present in nearly all cases of papilloma, whereas alterations in cell cycle genes and chromatin modifying genes were rarely observed, suggesting that papilloma was driven primarily by RAS pathway activation (Fig. 1e, Fisher’s exact test, p = 5.0E-5).